https://www.selleckchem.com/pr....oducts/remdesivir.ht
Aim The aim of this study was to investigate the significance of positive tuberculosis interferon gamma release assay (TB-IGRA) in the differential diagnosis of intestinal tuberculosis (IT and Crohn's disease (CD) patients, and to find a suitable threshold to help distinguishing CD from tuberculosis (T, so as to provide better recommendations for clinical treatment. Methods A retrospective study was performed including 484 patients who underwent TB-IGRA testing for suspected CD or ITB treated in the Shanghai Tenth People's Hospit